MALIGNANT OLIGODENDROGLIOMA

This adverse event was reported 27 times

These drugs are most commonly taken by patients reporting MALIGNANT OLIGODENDROGLIOMA:

# Drug Count
0 BEVACIZUMAB 5
1 ETANERCEPT 5
2 TEMOZOLOMIDE 4
3 ADALIMUMAB 2
4 CARBAMAZEPINE 2
5 INFLIXIMAB 2
6 LEVETIRACETAM 2
7 ABATACEPT 1
8 CARBOPLATIN 1
9 DIAZEPAM 1
See all common drugs associated with MALIGNANT OLIGODENDROGLIOMA

MALIGNANT OLIGODENDROGLIOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IVOSIDENIB 1 0.0005
1 LOMUSTINE 1 0.0004
2 TEMOZOLOMIDE 4 0.0002
3 BEVACIZUMAB 5 0.0000
4 IMATINIB MESYLATE 1 0.0000
5 CARBAMAZEPINE 2 0.0000
6 LACOSAMIDE 1 0.0000
7 LEVETIRACETAM 2 0.0000
8 ETOPOSIDE 1 0.0000
9 SULFASALAZINE 1 0.0000
See all drugs enriched for association with MALIGNANT OLIGODENDROGLIOMA